Active ingredientDegarelixCat. No. P-D035-001CAS 214766-78-6Family · Pharmaceutical analytical standards
Degarelix
A GnRH receptor antagonist, a synthetic peptide derived from the natural hormone, approved in the United States in 2008 and in Europe in 2009 for advanced prostate cancer: it lowers testosterone without the initial surge typical of agonists. This family brings together the active ingredient.
Did you know?After injection under the skin it spontaneously forms a gel-like depot, from which it is slowly released by diffusion over weeks.
Go to the active ingredient →Active ingredientDegarelixCat. No. P-D035-001CAS 214766-78-6
Active ingredientDegarelix AcetateCat. No. P-D035-002CAS 934016-19-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.